Trials / Completed
CompletedNCT04630860
A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD
A Randomized, Open-label, Multiple Ascending Dose Study in Patients With Advanced-stage Parkinson's Disease to Evaluate the Pharmacokinetics and Safety of LY03003 Following Intramuscular Injections
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Luye Pharma Group Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the pharmacokinetics and safety of LY03003 in patients with advanced-stage PD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY03003 | Rotigotine,extended-release microspheres |
Timeline
- Start date
- 2020-07-07
- Primary completion
- 2021-05-12
- Completion
- 2022-01-25
- First posted
- 2020-11-16
- Last updated
- 2023-05-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04630860. Inclusion in this directory is not an endorsement.